Weekly 20/56mg/m2 Carfilzomib, Lenalidomide and Dexamethasone until progression in Early Relapsed Refractory Multiple Myeloma - GRUCHET, Cecile; Richez, Valentine; Guidez, Stephanie; Sabirou, Florence; Moya, Niels; Levy, Anthony; Bobin, Arthur; Gardeney, Helene; Nsiala, Laly; Machet, Antoine; FOUQUET, Guillemette; Azais, Isabelle; et al. (Clinical lymphoma, myeloma and leukemia, 2019)